| scholarly article | Q13442814 |
| P2093 | author name string | Tae-Hwan Kwon | |
| Hye-Jeong Park | |||
| Hyo-Jung Choi | |||
| Hyun Jun Jung | |||
| Eui-Jung Park | |||
| Jeong-In Cho | |||
| P2860 | cites work | Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats | Q83840899 |
| Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II | Q24551154 | ||
| Wnt/beta-catenin signaling: components, mechanisms, and diseases | Q24630938 | ||
| The widespread regulation of microRNA biogenesis, function and decay | Q28131796 | ||
| The β-catenin destruction complex | Q28279593 | ||
| The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
| Long-term aldosterone treatment induces decreased apical but increased basolateral expression of AQP2 in CCD of rat kidney | Q28573221 | ||
| Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor | Q28578119 | ||
| Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus | Q28613481 | ||
| A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling | Q29619294 | ||
| Reduction of aldosterone production improves renal oxidative stress and fibrosis in diabetic rats | Q30415495 | ||
| Regulatory cascades involving calmodulin-dependent protein kinases | Q33813280 | ||
| Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells | Q34170239 | ||
| Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 | ||
| Aldosterone regulates microRNAs in the cortical collecting duct to alter sodium transport. | Q34427641 | ||
| Angiotensin II increases fibronectin and collagen I through the β-catenin-dependent signaling in mouse collecting duct cells | Q35086481 | ||
| Transcriptome analysis of human diabetic kidney disease | Q35180096 | ||
| Aldosterone in chronic kidney and cardiac disease | Q35205745 | ||
| MicroRNA-21 in glomerular injury | Q35228513 | ||
| Deep Sequencing in Microdissected Renal Tubules Identifies Nephron Segment-Specific Transcriptomes | Q35589079 | ||
| DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways | Q36088485 | ||
| Wnt and calcium signaling: beta-catenin-independent pathways | Q36228742 | ||
| A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions | Q36370996 | ||
| Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade | Q36689814 | ||
| Aldosterone induces mesangial cell apoptosis both in vivo and in vitro | Q36807031 | ||
| Wnt/beta-catenin signaling promotes renal interstitial fibrosis | Q37146468 | ||
| Role of aldosterone in the remnant kidney model in the rat. | Q37358980 | ||
| Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis | Q37580301 | ||
| Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury | Q37591248 | ||
| miR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction. | Q37681848 | ||
| Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome | Q37763640 | ||
| Wnt signaling in mammalian development: lessons from mouse genetics | Q38006924 | ||
| Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. | Q38016472 | ||
| Aldosterone and the kidney: a rapidly moving frontier (an update). | Q38160215 | ||
| Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1. | Q38289926 | ||
| Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2+-dependent phosphorylation of Smad2 at serine-240 | Q38291475 | ||
| The role of CaMKII in diabetic heart dysfunction | Q38551638 | ||
| Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog | Q38824254 | ||
| miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma. | Q38851246 | ||
| Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma | Q38861461 | ||
| Vasopressin-regulated miRNAs and AQP2-targeting miRNAs in kidney collecting duct cells | Q38913005 | ||
| miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes. | Q38916732 | ||
| Tankyrase-mediated β-catenin activity regulates vasopressin-induced AQP2 expression in kidney collecting duct mpkCCDc14 cells | Q38927549 | ||
| Molecular mechanisms regulating aquaporin-2 in kidney collecting duct | Q38985544 | ||
| Regulation of WNK1 Expression by miR-192 and Aldosterone | Q39660100 | ||
| MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy | Q40848218 | ||
| Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development | Q41088301 | ||
| MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a | Q41834977 | ||
| Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy | Q42371220 | ||
| Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11β-HSD activity | Q43143831 | ||
| Immunocytochemical and immunoelectron microscopic localization of alpha-, beta-, and gamma-ENaC in rat kidney | Q43607662 | ||
| Rapid stimulation of cyclic AMP production by aldosterone in rat inner medullary collecting ducts. | Q44214383 | ||
| Effect of aldosterone on renal transforming growth factor-beta | Q44886467 | ||
| The aggravating mechanisms of aldosterone on kidney fibrosis | Q46542770 | ||
| T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy | Q46804729 | ||
| Tubule-Derived Wnts Are Required for Fibroblast Activation and Kidney Fibrosis. | Q51088935 | ||
| MicroRNA-146a in Human and Experimental Ischemic AKI: CXCL8-Dependent Mechanism of Action. | Q51625604 | ||
| Calcium/calmodulin-dependent protein kinase II couples Wnt signaling with histone deacetylase 4 and mediates dishevelled-induced cardiomyopathy. | Q54303241 | ||
| Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells. | Q54309282 | ||
| Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone | Q57275237 | ||
| Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis | Q74568092 | ||
| Maintained ENaC trafficking in aldosterone-infused rats during mineralocorticoid and glucocorticoid receptor blockade | Q80121304 | ||
| Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker | Q83195202 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | ajprenal003582017 | |
| P577 | publication date | 2017-10-25 | |
| P1433 | published in | American Journal of Physiology - Renal Physiology | Q2610177 |
| P1476 | title | MiR-34c-5p and CaMKII are involved in aldosterone-induced fibrosis in kidney collecting duct cells |
Search more.